Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase 3 7Phase 4 3Phase 1 3Phase 1/2 2Phase NA 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3

Conditions

Leukemia, Promyelocytic, Acute 3Recurrence 1

Interventions

Idarubicin 3Arsenic Trioxide 3Mitoxantrone 2Cytarabine 2Tretinoin 1Transplantation, Autologous 1Thiotepa 1Radiotherapy 1Filgrastim 1Daunorubicin 1Cyclophosphamide 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Leukemia, Promyelocytic, Acute × Arsenic Trioxide × Clear all
NCT01987297 2019-08-19

Combined Retinoic Acid,Arsenic Trioxide and Chemo for Newly-diagnosed APL

Shanghai Jiao Tong University School of Medicine

Phase 4 Unknown
738 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

NCT00504764 2014-10-28

Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO)

PETHEMA Foundation

Phase 4 Completed
60 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

NCT00196768 2007-10-23

Treatment Protocol for Relapsed Acute Promyelocytic Leukemia (APL) With Arsenic

German AML Cooperative Group

Phase 4 Unknown
30 enrolled
Other hematologic neoplasm

Recurrence, Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡